These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34013378)

  • 1. Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells.
    Chiu YJ; Tsai FJ; Bau DT; Chang LC; Hsieh MT; Lu CC; Kuo SC; Yang JS
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells.
    Chiu YJ; Tsai FJ; Bau DT; Chang LC; Hsieh MT; Lu CC; Kuo SC; Yang JS
    Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells.
    Zuo Y; Xu H; Chen Z; Xiong F; Zhang B; Chen K; Jiang H; Luo C; Zhang H
    Oncol Rep; 2020 Jun; 43(6):1928-1944. PubMed ID: 32236631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
    Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
    Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
    Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
    Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
    Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.
    Sun E; Liu X; Lu C; Liu K
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
    Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastrol attenuates the inflammatory response by inhibiting IL‑1β expression in triple‑negative breast cancer cells.
    You D; Jeong Y; Yoon SY; A Kim S; Kim SW; Nam SJ; Lee JE; Kim S
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sericin inhibits MDA‑MB‑468 cell proliferation via the PI3K/Akt pathway in triple‑negative breast cancer.
    Niu L; Yang S; Zhao X; Liu X; Si L; Wei M; Liu L; Cheng L; Qiao Y; Chen Z
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
    Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C; Qiu S; Liu P; Ge Y; Gao X
    J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells.
    Zhang Y; Wang L; Gao P; Sun Z; Li N; Lu Y; Shen J; Sun J; Yang Y; Dai H; Cai H
    Int J Mol Med; 2018 Nov; 42(5):2343-2352. PubMed ID: 30226569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A.
    Kuo YH; Chiang EI; Chao CY; Rodriguez RL; Chou PY; Tsai SY; Pai MH; Tang FY
    Mol Cancer Ther; 2017 Mar; 16(3):480-493. PubMed ID: 27956520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
    Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
    Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.